Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

about

Dalbavancin treatment in a deep sternal wound MRSA infection after coronary artery bypass surgery: a case report.

P2860

Q48301411-9AE543EC-88CB-4E62-88A3-A150EE2C7A79

P2860

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

Item

http://www.wikidata.org/entity/Q39042375

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

@en

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

@nl

type

Item

label

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

@en

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

@nl

prefLabel

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

@en

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

@nl

P1476

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

@en

P2860

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Once-weekly dalbavancin versus daily conventional therapy for skin infection.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

In vivo pharmacodynamic activity of the glycopeptide dalbavancin

Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects.

Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection.

Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital.

P2888

s40265-016-0666-0

P304

75-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0666-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karly Garnock-Jones

P577

2016-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27988870

http://www.w3.org/2001/XMLSchema#string

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

about

P2860

P2860

Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698